AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 4th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 4th, 2017 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (as the same may be amended, restated, supplemented or otherwise modified from time to time hereafter, this “Agreement”) is effective as of April 12, 2017 (the “Effective Date”), and is entered into by and between Juniper Pharmaceuticals, Inc., a Delaware corporation having its corporate offices at 33 Arch St, Suite 3110, Boston, MA, 02110 (the “Company”), and Bridget A. Martell, MD MA (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 7th, 2017 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (as the same may be amended, restated, supplemented or otherwise modified from time to time hereafter, this “Agreement”) is entered into by and between Columbia Laboratories, Inc., a Delaware corporation having its corporate offices at 4 Liberty Square, Boston, MA, 02109 (the “Company”), and Bridget A. Martell, MD MA (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 26th, 2014 • Columbia Laboratories Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 26th, 2014 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (as the same may be amended, restated, supplemented or otherwise modified from time to time hereafter, this “Agreement”) is entered into by and between Columbia Laboratories, Inc., a Delaware corporation having its corporate offices at 4 Liberty Square, Boston, MA, 02109 (the “Company”), and George O. Elston (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 16th, 2013 • Columbia Laboratories Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 16th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (as the same may be amended, restated, supplemented or otherwise modified from time to time hereafter, this “Agreement”) is entered into by and between Columbia Laboratories, Inc., a Delaware corporation having its corporate offices at 354 Eisenhower Parkway, Livingston, New Jersey 07039 (the “Company”), and Jonathan B. Lloyd Jones (“Executive”).